Skip to content

Author

Tsubasa Tsutsumi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.

AIM Although steatotic liver disease (SLD) has been associated with chronic kidney disease (CKD), it remains unclear whether CKD-related outcomes are driven by hepatic steatosis itself or by accompanying cardiometabolic abnormalities. We investigated the relative contribution of hepatic steatosis and cardiometabolic ri...

Michihiro Iwaki, Hideki Fujii, Yoshihiro Kamada et al. · 0 citations
Review Open access Aug 2026

Review Article: Fibrosis Reversal in Metabolic Dysfunction-Associated Steatohepatitis-The Promise of Emerging Therapeutics.

Fibrosis improvement in MASH is attainable by available drugs with further promise from emerging therapies, and a rich therapeutic pipeline with the promise of combination regimens and increased focus non-invasive endpoints suggests that the future looks bright for patients living with fibrotic MASH.

Malek Ayoub, Tsubasa Tsutsumi, M. Rinella · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.